Pacer Advisors, Inc. Ironwood Pharmaceuticals Inc Transaction History
Pacer Advisors, Inc.
- $38.6 Billion
- Q1 2024
A detailed history of Pacer Advisors, Inc. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Pacer Advisors, Inc. holds 7,206,187 shares of IRWD stock, worth $47 Million. This represents 0.16% of its overall portfolio holdings.
Number of Shares
7,206,187Holding current value
$47 Million% of portfolio
0.16%Shares
14 transactions
Others Institutions Holding IRWD
# of Institutions
296Shares Held
170MCall Options Held
27.1MPut Options Held
2.28M-
Black Rock Inc. New York, NY24.2MShares$158 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.5MShares$127 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$107 Million24.97% of portfolio
-
State Street Corp Boston, MA13.9MShares$90.7 Million0.01% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny7.1MShares$46.3 Million0.1% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $999M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...